Natalizumab treatment in multiple sclerosis: the experience from two Brazilian MS centers

Objective Analyze the demographics, clinical characteristics, efficacy and safety of natalizumab treatment in Brazilian patients with multiple sclerosis (MS) followed up for at least 12 months, in two tertiary MS care centers in São Paulo.Method We evaluated the effect of natalizumab treatment on an...

Full description

Bibliographic Details
Main Authors: Enedina Maria Lobato de Oliveira, Renata Faria Simm, Gorana Dasic, Marília Mamprim de Morais, Samira Luiza dos Apostolos Perreira, Dagoberto Callegaro
Format: Article
Language:English
Published: Academia Brasileira de Neurologia (ABNEURO) 2015-09-01
Series:Arquivos de Neuro-Psiquiatria
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X2015000900736&lng=en&tlng=en